We are firm believers that increasing access to affordable, evidence-based care can lower overall healthcare costs and improve outcomes.
Rather than focus on disruption for disruption’s sake, we’re building a services infrastructure to link the healthcare ecosystem to patients, on their terms.
Our business model is designed to augment provider workforces, not replace them. We enable continuous interactions between physicians and their patients, no disjointed black box encounters. And we do this at a price point that can lower the cost of care, not increase it.
How? We are scaling a highly-skilled, W2 workforce of phlebotomists and nurses (“Sprinters”) who go into patients’ homes to perform a variety of services that equip their providers to make the best decisions – all at a price point of $50-$100 per visit.
This menu of services is just the beginning. With a medical practice responsible for all clinical operations, we have the flexibility to add capabilities for immunizations and injections, medication reconciliation, and other clinical tasks ordered by our provider partners in the near future.
During each visit, Sprinters follow a detailed checklist of protocols validated by our partners and customized for each patient. This provides an extra layer of quality control and creates personal touchpoints tailored to each individual’s healthcare needs. Whether it’s a social determinants screening or a blood pressure reading, Sprinters know exactly what services to provide and are trained to deliver care with empathy and compassion.
In recent years, there have been great strides in moving healthcare closer to the patient - whether it’s through local pharmacies, pop-up screening events, or virtual interactions. We’re working to bring care a step closer, by meeting patients in their home or workplace with a friendly, trusted healthcare professional.
While in-home care is available today, access is limited by the high cost of sending medical decision-makers into the home - reflected in the current focus on acute interventions and risk adjustment, as well as Medicare’s homebound requirement for home health services. Our approach enables broader access to in-home care while delivering a terrific experience for patients (our current NPS is 92!). By focusing strictly on data collection and task execution in accordance with evidence-based protocols, your staff can spend more time delivering care, the patient-provider relationship is not disrupted, and continuity of care is maintained.
We’re not saying every patient should receive all care from their home. For the highly compliant patients seeing their physician in person today, it is likely more efficient to maintain the status quo.
But what about patients with mobility limitations? Or those experiencing social isolation or technology barriers? Maybe there are competing life circumstances causing them to delay care? And what about patients facing cancer, burdened with countless trips into a facility for labs, treatment, and consults? We believe that the simple intervention of expanding access to in-home services can have a dramatic impact on patients’ healthcare experience, engagement, and outcomes.
The increasing adoption of value-based payment models is forcing the delivery of care to be more efficient. Our system is starting to prioritize proactive population medicine that delivers more personalized care to patients while placing a premium on prevention and intervention.
We’re building the infrastructure to support new hybrid care models that thrive under this patient-centric framework, and we’re looking to accelerate this future by investing in strategic partnerships with organizations that share our vision of bringing easy access to care for those who need it most.
If this sounds like a future you’d like to build, let’s talk.